معرفی
Dr. Jane Holmes-Walker is a Clinical Professor in the Department of Endocrinology at the Westmead Clinical School, University of Sydney. She is also a staff specialist at Westmead Hospital and holds a PhD in Medicine (1999) from the University of Sydney, focusing on mitochondrial DNA mutations in diabetes. Her clinical expertise includes endocrinology and diabetes care, with a strong focus on improving transition from pediatric to adult diabetes care for young people. She has developed key clinical services such as the Diabetes Transition Support Program and the Adult Genetic Metabolic Disease Service.
Research interests span clinical islet cell transplantation, insulin pump therapy, closed-loop glucose monitoring systems, and the impact of androgen deprivation therapy on bone metabolism in prostate cancer patients. She is actively involved in national guideline development for cystic fibrosis-related diabetes and type 1 diabetes management. Dr. Holmes-Walker coordinates endocrinology teaching at Westmead, emphasizing long-case clinical training.
- Education: PhD in Medicine (University of Sydney, 1999), training at Westmead Hospital and institutions in London.
- Key Roles: ACI Transition Committee member, author of >20 peer-reviewed publications.
- Funding: 2019 grant for insulin pump implementation in adolescents with type 2 diabetes.
Her work integrates clinical innovation with patient-centered care, addressing gaps in transitional healthcare and advancing diabetes technology adoption.
